NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial LaunchPRNewsWire • 07/30/21
NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine SurgeryPRNewsWire • 07/22/21
FDA Flags Certain Biocompatibility Concerns For NuVasive's Orthopedics' Precice DevicesBenzinga • 07/09/21
NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical EvaluationsPRNewsWire • 06/30/21
NuVasive, Inc. (NUVA) CEO Chris Barry on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Analysts Estimate NuVasive (NUVA) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/28/21